Getein Biotech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	1,108	1,046	1,149	1,355	1,816	1,398
Other Revenue	5.98	5.98	15.58	14.45	6.18	3.62
Revenue	1,114	1,052	1,165	1,369	1,822	1,402
Revenue Growth	6.86%	-9.71%	-14.93%	-24.85%	29.98%	24.78%
Cost of Revenue	357.19	339.6	388.07	479.71	671.56	485.42
Gross Profit	756.99	712.11	776.73	889.45	1,150	916.29
Selling, General & Admin	309.46	311.82	357.92	439.87	407.26	324.08
Research & Development	157.9	157.4	181.21	217.99	223.22	163.39
Other Operating Expenses	1.05	4.91	3.17	0.14	-0.07	12.55
Operating Expenses	469.66	503.24	556	677.22	653.29	506.69
Operating Income	287.33	208.88	220.73	212.24	497.01	409.59
Interest Expense	-8.7	-12.09	-14.93	-16.94	-16.61	-14.31
Interest & Investment Income	68.11	33.09	45.79	72.02	45.5	47.97
Currency Exchange Gain (Loss)	-7.06	-7.06	5.8	11.31	19.41	-0.97
Other Non Operating Income (Expenses)	-4.02	-0.38	-0.49	-0.54	-3.29	-4.42
EBT Excluding Unusual Items	335.66	222.43	256.9	278.09	542.03	437.86
Impairment of Goodwill	-	-	-25.83	-	-	-
Gain (Loss) on Sale of Investments	17.57	18.29	0.15	10.25	18.46	-4.29
Gain (Loss) on Sale of Assets	0.13	-0.05	1.59	0.67	0.02	0.95
Asset Writedown	-37.05	-18.55	-5.32	-1.69	-0.53	-
Other Unusual Items	5.57	5.57	25.93	17.63	-	17.11
Pretax Income	321.88	227.69	253.43	304.94	559.98	451.63
Income Tax Expense	29.36	15.77	23.55	20.86	56.03	39.62
Earnings From Continuing Operations	292.53	211.92	229.88	284.08	503.94	412.01
Minority Interest in Earnings	-0.01	8.74	-6.24	-4.31	-5.03	-13.02
Net Income	292.52	220.66	223.64	279.77	498.91	398.99
Net Income to Common	292.52	220.66	223.64	279.77	498.91	398.99
Net Income Growth	40.12%	-1.33%	-20.06%	-43.92%	25.04%	30.93%
Shares Outstanding (Basic)	504	502	508	509	509	505
Shares Outstanding (Diluted)	504	502	508	509	509	512
Shares Change	-0.88%	-1.33%	-0.08%	-0.08%	-0.48%	0.72%
EPS (Basic)	0.58	0.44	0.44	0.55	0.98	0.79
EPS (Diluted)	0.58	0.44	0.44	0.55	0.98	0.78
EPS Growth	41.37%	0%	-20.00%	-43.88%	25.64%	30.00%

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	321.78	242.01	266.6	75.09	265.51	252.77
Free Cash Flow Per Share	0.64	0.48	0.53	0.15	0.52	0.49
Dividend Per Share	0.300	0.240	0.180	0.200	0.340	0.243
Dividend Growth	66.67%	33.33%	-10.00%	-41.18%	39.98%	32.30%
Gross Margin	67.94%	67.71%	66.68%	64.96%	63.14%	65.37%
Operating Margin	25.79%	19.86%	18.95%	15.50%	27.28%	29.22%
Profit Margin	26.25%	20.98%	19.20%	20.43%	27.38%	28.46%
Free Cash Flow Margin	28.88%	23.01%	22.89%	5.49%	14.57%	18.03%
EBITDA	365.63	291.01	307.96	297.73	561.95	457.04
EBITDA Margin	32.82%	27.67%	26.44%	21.75%	30.84%	32.61%
D&A For EBITDA	78.3	82.13	87.23	85.49	64.93	47.44
EBIT	287.33	208.88	220.73	212.24	497.01	409.59
EBIT Margin	25.79%	19.86%	18.95%	15.50%	27.28%	29.22%
Effective Tax Rate	9.12%	6.93%	9.29%	6.84%	10.01%	8.77%
Revenue as Reported	1,114	1,052	1,165	1,369	1,822	1,402
Advertising Expenses	-	18.35	20.46	43.56	47.32	36.19